RBP2 and glioblastoma: KDM5A, also known as retinoblastoma binding protein (RBP2), was initially identified as a binding partner of retinoblastoma protein, and its overexpression has been observed in cancers such as glioblastoma, gastric cancer [39], hepatocellular carcinoma, and lung cancer [40].